QUIT last traded at $5.56. On daily bars, all of the trend and momentum measures below are currently negative.
•The 50-day simple moving average is $6.96, so QUIT is trading below its 50-day average.
•The 200-day simple moving average is $5.75, so QUIT is trading below its 200-day average — the level most often used to separate a long-term uptrend from a downtrend.
•The 50-day average is above the 200-day, the configuration known as a golden cross.
•The 14-day RSI is 31.5 — between 30 and 70, which is the neutral band.
•The MACD line is -0.31 against a signal line of -0.23, so MACD is below its signal line.
•Over the past year QUIT has traded between $2.62 and $8.64, putting it 49% of the way up that range.
•Volume on the latest session was 1.9M shares against a 20-day average of 1.1M — 1.7× the average.
RSI (14)
31.5
ACHIEVE LIFE SCIENCES, INC.
Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence.Its New Drug Application (NDA) for cytisinicline for smoking cessation in adults is supported by two completed Phase 3 studies and an open-label long-term safety study. It has also completed a Phase 2 study of cytisinicline in nicotine e-cigarette cessation, conducted an end-of-Phase 2 meeting with the FDA, and has received Breakthrough Therapy designation for the vaping cessation indication.